Hopkins Researchers Find Genetic Colon Cancer Change In Healthy Cells

November 03, 1998

October 27, 1998

Johns Hopkins scientists have found a genetic alteration associated with common forms of colon cancer in patients' normal cells. The same abnormality, called loss of imprinting (LOI), also appears, the researchers say, in a significant number of healthy people, offering a possibility of predicting as many as 40 percent of new colon cancer cases before they start.

"It's the first cancer-related genetic alteration found at high frequency in healthy people," says Andrew P. Feinberg, M.D., who with Hengmi Cui, Ph.D., led the study appearing in this month's Nature Medicine. By contrast, APC and HNPCC, the known colon cancer genes that predict high risk of the disease, together account for less than 3 percent of new cases.

In the study, the Hopkins team analyzed both tumors and normal parts of the colon in 30 patients with colon cancer, looking for loss of imprinting. LOI -- a recently discovered phenomenon with a strong tie to cancer and other diseases -- refers to an abnormal switching-on or off of genes.

People inherit copies of the same gene from both parents, and both genes or sets of genes work in tandem in a person's cells. In normal development, in a process called imprinting, the copy from one parent, in certain genes, is turned off. This inherited preferential silencing usually holds throughout all cells in a person's body.

In their investigations of cancer, however, researchers have learned that such genes can lose their imprinting. "We know there is a link between LOI and cancer," Feinberg says, "because we've repeatedly found LOI in cancers, notably in genes that either encourage cell growth or that suppress cancer." Earlier work by Feinberg and by others has showed, for example, that LOI appears frequently in Wilms' tumor, the most common non-blood cancer in children.

In this new study, researchers focused on a specific growth-promoting gene called IGF2 (for insulin-like growth factor), one of several cell growth genes normally imprinted so that only the father's gene gets expressed. But in 44 percent of the cancer patients, that imprinting was lost in their tumor cells.

"Even more surprising to us," says Cui, "was the appearance of LOI in these patients' healthy colon tissue and blood cell samples." Finding such flaws in healthy cells is rare, he adds.

Thirteen percent of the study's 31 control patients, with no sign of cancer, also tested positive for LOI in colon tissues or blood. Before doctors can use LOI to screen patients, however, Feinberg says the studies must extend to a large number of healthy people. "Further research will be needed to establish LOI's predictive value," says Feinberg.

What strengthens the case for LOI's cancer-predicting potential is a link, in this study, between LOI in healthy cells and a second defect found in the actual cancers. This defect, called microsatellite instability (MSI), involves an unusual duplication of certain stretches of DNA -- a sign of a glitch in the way DNA reproduces or repairs itself. Oncologists associate MSI with cancers that come at a relatively early age and run in families. Some use MSI to predict a patient's outcome.

When the Hopkins researchers examined the colon cancer patients' normal cells, they found that those with abnormal imprinting were "for the most part, the same people with MSI," says Feinberg. And those same patients got colon cancer 14 years earlier than the others, on average.

"We don't yet know if LOI is causal for cancer," says Feinberg. Knowing that, he says, would be especially useful because, unlike conventional mutations, LOI is potentially reversible.

Imprinting was first linked to cancer about a decade ago, with the childhood tumor, rhabdomyosarcoma. In addition to Wilms' tumor, LOI is also definitely implicated in Prader-Willi syndrome, which causes retardation, and in some adult lung cancers.

The most striking case of large-scale genome imprinting involves crosses between horses and donkeys. Cross a female horse and a male donkey and you get a mule. Cross a male horse and a female donkey and you get a hinny, altogether a different creature. Clearly, the same genes act out different roles, depending on whether they come from "mom" or "dad."

Other members of the research team were Stanley R. Hamilton, M.D., and Rolf Ohlsson, of the University of Uppsala, Sweden.
A patent is pending on the techniques in this research.

Funding for this study was from NIH grants.
-end-
Media Contact: Marjorie Centofanti (410)955-8725
E-mail: mcentofanti@jhmi.edu

Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu,
Quadnet at http://www.quad-net.com and ScienceDaily at http://www.sciencedaily.com.
-end-


Johns Hopkins Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.